Navigation Links
Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine

A powerful headache medicine, Dr. Mauskop's Migralex™, developed by a leading neurologist, Dr. Alexander Mauskop, renowned headache expert and founder of the New York Headache Center, is now available to America’s 100 million headache sufferers.

New York (Vocus) December 9, 2009 -- A powerful headache medicine developed by a leading neurologist for his own patients is now available to America’s 100 million headache sufferers, only 29 percent of whom are satisfied with their current headache treatments.

Dr. Alexander Mauskop, renowned headache expert and founder of the New York Headache Center is the creator of Dr. Mauskop’s Migralex™, the strongest combination headache medicine available without a prescription.

Rather than relying on drugs that simply diminish discomfort, Dr. Mauskop’s Migralex™ targets stubborn pain at its source, correcting metabolic imbalances that trigger headaches. This innovative strategy brings quick relief, while freeing patients from the potential complications that accompany many popular medicines.

“I didn’t want my patients to suffer from the serious side effects seen with many headache drugs, problems like agitation, anxiety, insomnia, nausea, muscle cramps and headaches that become even worse,” explains Dr. Mauskop, a long-time headache sufferer himself.

“Headaches can drive you up the wall and make you try all sorts of medications. But sooner or later you’ll probably come to the conclusion that I did, that modern medicine doesn’t always give us what we seek: safe, reliable control over pain.”

Convinced there had to be a better way, Dr. Mauskop launched a 20-year quest to uncover the cause of headaches and to find alternatives to conventional drugs. His breakthrough research, conducted with Drs. Bella and Burton Altura, revealed that many headache sufferers share a common magnesium deficiency that results in a variety of neurochemical abnormalities. These imbalances cause brain and blood vessel changes in the head that trigger pain.

The doctor created a formula that combines precise amounts of quickly dissolving ingredients capable of delivering fast results with minimal side effects.

Those lucky enough to try the new approach quickly dubbed it a “miracle,” “effective” and “excellent.” However, as word of Dr. Mauskop’s research spread to professional journals, fellow physicians, national media outlets, and headache sufferers everywhere, the clamor for the new medication grew. The doctor answered the call with the release of his over-the-counter product on December 10, 2009.

“I introduced this patented medicine because I want to help many more headache sufferers than just my patients,” underlines Dr. Mauskop.

Now, everyone can take two caplets with a full glass of water to experience the relief previously enjoyed only by patients at the respected New York Headache Center.

Dr. Mauskop’s Migralex™ is fast acting, free of sodium, caffeine and preservatives, and is clinically proven to ease headaches brought on by sinus pain, stress, tension, menstruation, and exertion. The formula reduces inflammation, inhibits the clumping together of platelets, relaxes blood vessels and normalizes dozens of chemical reactions, while successfully and rapidly attacking pain.

With Dr. Mauskop’s Migralex™ widely available at the and websites and at select local pharmacies, the product’s originator is thrilled that many more people can enjoy genuine relief.

“There is simply no reason to be sidelined with an awful headache when such a quick, safe and effective medication is available,“ Dr. Mauskop concludes.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Leading Orthopaedic Surgeon Thomas A. Einhorn Offers Breakthrough Non-Embryonic Stem Cell Surgery to Reverse Early Necrosis of the Hip
2. Atlanta Snoring Institute Uses Breakthrough Techniques to Treat Sinusitis and Sinus Pain
3. Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose
4. Stroke Survivors Improve Walking, Confidence Level and Quality of Life With Breakthrough Device
5. First results from major European patient survey show devastating impact of living with breakthrough cancer pain
6. Instanyl sets new standard in management of breakthrough cancer pain
7. First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain
8. Potential Breakthrough Cancer Treatment Now Available From Vascular Designs
9. Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results
10. Stem Cell Treatment Breakthrough
11. Breakthrough Technology Harnesses Microorganism for Use as Green Bio-Pesticide
Post Your Comments:
Related Image:
Breakthrough Approach to Age-old Ailment, Renowned Doctor Introduces Powerful Headache Medicine
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... solution provider of IBM software products, introduced a new company, RightSensor™ LLC, an ... and data communications capability. RightSensor™ provides a fully-managed approach for customers requiring ...
(Date:10/13/2015)... , ... October 13, 2015 , ... Dr. Poneh Ghasri, ... New Today on September 18, 2015. The research, which was conducted at the Dental ... Sabbah and colleagues, show connections between stress during pregnancy and future dental health in ...
(Date:10/13/2015)... ... ... A child without a healthy mouth is much more likely to have an ... has joined with Global Dental Relief (GDR) to help bring dental care ... SmileCareClub will donate one clinic visit to a child in Kenya. , “When SmileCareClub ...
(Date:10/13/2015)... ... October 13, 2015 , ... Altec Products, Inc., the ... of Synergy 2015. The annual WennSoft KEY2ACT user conference will take place from ... unite customers, partners, WennSoft team members and sponsors to facilitate the sharing of ...
(Date:10/13/2015)... ... 13, 2015 , ... T-System and Centegra Health System, a ... department visits per year, today announced the successful and rapid deployment of EV™, ... and financial outcomes. , In less than four days, Centegra Hospitals ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Calif. , Oct. 13, 2015  Asterias ... agreement with the UK-based Cell Therapy Catapult to ... AST-VAC2, Asterias, allogeneic dendritic cell immunotherapy. Under the ... scale manufacturing processes for AST-VAC2 to support advanced ... --> --> The ...
(Date:10/12/2015)... -- Use this report to: - Learn ... the medical membrane devices market. - Analyze the present ... medical membrane devices market including hemodialyzers, membrane oxygenators, intravenous ... devices. - Gain information on newly approved products, recalls ... Use this report to: - Learn about the performance, ...
(Date:10/12/2015)... Texas , Oct. 12, 2015  Luminex Corporation (NASDAQ: ... results for the third quarter ended September 30, 2015 on ... is scheduled for release after the close of trading. ... hold a conference call to discuss the operating highlights and ... on November 2, 2015, at 4:30 p.m. Eastern time. ...
Breaking Medicine Technology: